Oncologic imaging: a guiding hand of personalized cancer care
- PMID: 21493796
- DOI: 10.1148/radiol.11110252
Oncologic imaging: a guiding hand of personalized cancer care
Similar articles
-
Personalized medicine in oncology, the potential role of nuclear medicine imaging.Curr Pharm Des. 2014;20(14):2231-3. doi: 10.2174/13816128113196660669. Curr Pharm Des. 2014. PMID: 24025097 No abstract available.
-
Diagnostic imaging in oncology. Proceedings of a meeting. Naples, Italy, 28-30 April 1993.Nucl Med Biol. 1994 Jul;21(5):681-792. Nucl Med Biol. 1994. PMID: 9289312 No abstract available.
-
2015 ASCO Annual Meeting.Lancet Oncol. 2015 Jul;16(7):755-6. doi: 10.1016/S1470-2045(15)00025-X. Epub 2015 Jun 7. Lancet Oncol. 2015. PMID: 26062778 No abstract available.
-
Imaging requirements for personalized medicine: the oncologists point of view.Curr Pharm Des. 2014;20(14):2234-49. doi: 10.2174/13816128113196660668. Curr Pharm Des. 2014. PMID: 24025098 Review.
-
Translational molecular imaging for cancer.Cancer Imaging. 2005 Nov 23;5 Spec No A(Spec No A):S16-26. doi: 10.1102/1470-7330.2005.0101. Cancer Imaging. 2005. PMID: 16361132 Free PMC article. Review.
Cited by
-
[Imaging in oncology: terms and definitions].Radiologe. 2013 Apr;53(4):303-12. doi: 10.1007/s00117-012-2431-z. Radiologe. 2013. PMID: 23536031 German.
-
Targeted theranostic nanomedicine using targeted CT-imageable particles that release tebentafusp.Jpn J Radiol. 2025 Aug;43(8):1393-1407. doi: 10.1007/s11604-025-01782-w. Epub 2025 Apr 17. Jpn J Radiol. 2025. PMID: 40244495 Free PMC article.
-
Medical imaging in personalised medicine: a white paper of the research committee of the European Society of Radiology (ESR).Insights Imaging. 2011 Dec;2(6):621-630. doi: 10.1007/s13244-011-0125-0. Epub 2011 Sep 29. Insights Imaging. 2011. PMID: 22347981 Free PMC article.
-
The future of radiology.Rambam Maimonides Med J. 2011 Jul 31;2(3):e0059. doi: 10.5041/RMMJ.10059. Print 2011 Jul. Rambam Maimonides Med J. 2011. PMID: 23908817 Free PMC article. No abstract available.
-
Tumor volume decrease at 8 weeks is associated with longer survival in EGFR-mutant advanced non-small-cell lung cancer patients treated with EGFR TKI.J Thorac Oncol. 2013 Aug;8(8):1059-68. doi: 10.1097/JTO.0b013e318294c909. J Thorac Oncol. 2013. PMID: 23787800 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical